190 related articles for article (PubMed ID: 28829913)
1. Virtual Screening of Acyclovir Derivatives as Potential Antiviral Agents: Design, Synthesis, and Biological Evaluation of New Acyclic Nucleoside ProTides.
Derudas M; Vanpouille C; Carta D; Zicari S; Andrei G; Snoeck R; Brancale A; Margolis L; Balzarini J; McGuigan C
J Med Chem; 2017 Sep; 60(18):7876-7896. PubMed ID: 28829913
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activity of cyclosaligenyl prodrugs of acyclovir, carbovir and abacavir.
Balzarini J; Haller-Meier F; De Clercq E; Meier C
Antivir Chem Chemother; 2001 Sep; 12(5):301-6. PubMed ID: 11900349
[TBL] [Abstract][Full Text] [Related]
3. The application of phosphoramidate protide technology to acyclovir confers anti-HIV inhibition.
Derudas M; Carta D; Brancale A; Vanpouille C; Lisco A; Margolis L; Balzarini J; McGuigan C
J Med Chem; 2009 Sep; 52(17):5520-30. PubMed ID: 19645484
[TBL] [Abstract][Full Text] [Related]
4. A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2.
Vanpouille C; Lisco A; Derudas M; Saba E; Grivel JC; Brichacek B; Scrimieri F; Schinazi R; Schols D; McGuigan C; Balzarini J; Margolis L
J Infect Dis; 2010 Feb; 201(4):635-43. PubMed ID: 20085496
[TBL] [Abstract][Full Text] [Related]
5. A new acyclic heterodinucleotide active against human immunodeficiency virus and herpes simplex virus.
Franchetti P; Abu Sheikha G; Cappellacci L; Marchetti S; Grifantini M; Balestra E; Perno C; Benatti U; Brandi G; Rossi L; Magnani M
Antiviral Res; 2000 Sep; 47(3):149-58. PubMed ID: 10974367
[TBL] [Abstract][Full Text] [Related]
6. Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues.
Lisco A; Vanpouille C; Tchesnokov EP; Grivel JC; Biancotto A; Brichacek B; Elliott J; Fromentin E; Shattock R; Anton P; Gorelick R; Balzarini J; McGuigan C; Derudas M; Götte M; Schinazi RF; Margolis L
Cell Host Microbe; 2008 Sep; 4(3):260-270. PubMed ID: 18779052
[TBL] [Abstract][Full Text] [Related]
7. Prodrugs of γ-Alkyl-Modified Nucleoside Triphosphates: Improved Inhibition of HIV Reverse Transcriptase.
Zhao C; Weber S; Schols D; Balzarini J; Meier C
Angew Chem Int Ed Engl; 2020 Dec; 59(49):22063-22071. PubMed ID: 32379948
[TBL] [Abstract][Full Text] [Related]
8. Phosphoramidate derivatives of acyclovir: synthesis and antiviral activity in HIV-1 and HSV-1 models in vitro.
Zakirova NF; Shipitsyn AV; Jasko MV; Prokofjeva MM; Andronova VL; Galegov GA; Prassolov VS; Kochetkov SN
Bioorg Med Chem; 2012 Oct; 20(19):5802-9. PubMed ID: 22954898
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of novel nucleoside and nucleotide analogues as agents against DNA viruses and/or retroviruses.
Hakimelahi GH; Ly TW; Moosavi-Movahedi AA; Jain ML; Zakerinia M; Davari H; Mei HC; Sambaiah T; Moshfegh AA; Hakimelahi S
J Med Chem; 2001 Oct; 44(22):3710-20. PubMed ID: 11606136
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of phosphorodiamidate prodrugs of antiviral and anticancer nucleosides.
McGuigan C; Bourdin C; Derudas M; Hamon N; Hinsinger K; Kandil S; Madela K; Meneghesso S; Pertusati F; Serpi M; Slusarczyk M; Chamberlain S; Kolykhalov A; Vernachio J; Vanpouille C; Introini A; Margolis L; Balzarini J
Eur J Med Chem; 2013; 70():326-40. PubMed ID: 24177359
[TBL] [Abstract][Full Text] [Related]
11. Acyclic nucleosides as antiviral compounds.
Freeman S; Gardiner JM
Mol Biotechnol; 1996 Apr; 5(2):125-37. PubMed ID: 8734425
[TBL] [Abstract][Full Text] [Related]
12. Flexibility as a Strategy in Nucleoside Antiviral Drug Design.
Peters HL; Ku TC; Seley-Radtke KL
Curr Med Chem; 2015; 22(34):3910-21. PubMed ID: 26282942
[TBL] [Abstract][Full Text] [Related]
13. New acyclic quinoxaline nucleosides. Synthesis and anti-hiv activity.
Ali IA; Al-Masoudi IA; Aziz NM; Al-Masoudi NA
Nucleosides Nucleotides Nucleic Acids; 2008 Feb; 27(2):146-56. PubMed ID: 18205069
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel distamycin-modified nucleoside analogues as HIV-1 reverse transcriptase inhibitors.
Li C; Ma C; Zhang J; Qian N; Ding J; Qiao R; Zhao Y
Antiviral Res; 2014 Feb; 102():54-60. PubMed ID: 24342709
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of Human Immunodeficiency Virus type 1 (HIV-1) by a novel family of tricyclic nucleosides.
Bonache MC; Cordeiro A; Quesada E; Vanstreels E; Daelemans D; Camarasa MJ; Balzarini J; San-Félix A
Antiviral Res; 2011 Oct; 92(1):37-44. PubMed ID: 21600933
[TBL] [Abstract][Full Text] [Related]
16. Structure-Activity Relationships of Acyclic Selenopurine Nucleosides as Antiviral Agents.
Sahu PK; Umme T; Yu J; Kim G; Qu S; Naik SD; Jeong LS
Molecules; 2017 Jul; 22(7):. PubMed ID: 28704950
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anti-HIV evaluation of 3'-triazolo nucleosides.
Roy V; Obikhod A; Zhang HW; Coats SJ; Herman BD; Sluis-Cremer N; Agrofoglio LA; Schinazi RF
Nucleosides Nucleotides Nucleic Acids; 2011 Apr; 30(4):264-70. PubMed ID: 21623540
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 3'-halo-5'-norcarbocyclic nucleoside phosphonates as potent anti-HIV agents.
Hamon N; Kaci M; Uttaro JP; Périgaud C; Mathé C
Eur J Med Chem; 2018 Apr; 150():642-654. PubMed ID: 29558735
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of 3-benzyloxy-linked pyrimidinylphenylamine derivatives as potent HIV-1 NNRTIs.
Rai D; Chen W; Tian Y; Chen X; Zhan P; De Clercq E; Pannecouque C; Balzarini J; Liu X
Bioorg Med Chem; 2013 Dec; 21(23):7398-405. PubMed ID: 24134904
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of V75I HIV-1 reverse transcriptase mutant selected in vitro by acyclovir to anti-HIV drugs.
McMahon MA; Siliciano JD; Kohli RM; Siliciano RF
AIDS; 2010 Jan; 24(2):319-23. PubMed ID: 20009920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
